help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on January 30, 2004, doi:10.1165/rcmb.2003-0223OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-0223OCv1
30/6/886    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oshiro, A.
Right arrow Articles by Inagaki, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oshiro, A.
Right arrow Articles by Inagaki, C.
American Journal of Respiratory Cell and Molecular Biology. Vol. 30, pp. 886-892, 2004
© 2004 American Thoracic Society
DOI: 10.1165/rcmb.2003-0223OC

Protease-Activated Receptor-2–Mediated Inhibition for Ca2+ Response to Lipopolysaccharide in Guinea Pig Tracheal Epithelial Cells

Akihiro Oshiro, Hitomi Otani, Yasuhiro Yagi, Shirou Fukuhara and Chiyoko Inagaki

Department of Pharmacology and Department of Internal Medicine 1, Kansai Medical University, Osaka, Japan

Address correspondence to: Chiyoko Inagaki, M.D., Department of Pharmacology, Kansai Medical University, Moriguchi, Osaka 570-8506, Japan. E-mail: inagaki{at}takii.kmu.ac.jp

The protease-activated receptor-2 (PAR-2) has been implicated in airway inflammation. Here, we examined the interaction between PAR-2 and lipopolysaccharide (LPS), a major proinflammatory factor, using cultured guinea pig tracheal epithelial cells. In fura2-loaded cells, LPS (1 µg/ml) transiently increased intracellular Ca2+ concentrations ([Ca2+]i), this effect being abolished by a Ca2+ channel blocker, verapamil, and Ca2+ removal. Prestimulation of PAR-2 with trypsin (0.1–1 U/ml) or an agonist peptide (SLIGRL-NH2, 1 µM) for 60 min inhibited the LPS-induced [Ca2+]i increase. Such an inhibitory effect of trypsin was abolished by inhibitors of protein kinase C (PKC), chelerythrine and staurosporine. A PKC activator, phorbol 12,13-dibutylate, also reduced the LPS response. Trypsin also inhibited a transient increase in [Ca2+]i caused by a Ca2+ channel opener, Bay K 8644. When the trypsin-pretreated cells were incubated in normal buffer for 10–60 min before LPS exposure, the effect of trypsin on the Ca2+ response to LPS diminished in a time-dependent manner. Such a recovery was slowed by incubation with a protein phosphatase inhibitor, okadaic acid. Further, trypsin induced sustained activations of PKC{alpha} and -{epsilon}. Thus, PAR-2 stimulation reduced the epithelial cell response to LPS, probably through the inactivation of Ca2+ channels via PKC-mediated phosphorylation.

Abbreviations: 1,4-Dihydro-2, 6-dimethyl-5-nitro-4-[2'-(trifluoromethyl)phenyl]-3-pyridinecarboxylic acid methyl ester, (±)-Bay K 8644 • fetal calf serum, FCS • intracellular Ca2+ concentration, [Ca2+]i • Joklik's modified Eagle's medium, JMEM • lipopolysaccharide, LPS • protease-activated receptor, PAR • phorbol 12, 13-dibutylate, PDBu • cAMP-dependent protein kinase, PKA • protein kinase C, PKC • cGMP-dependent protein kinase, PKG • soybean trypsin inhibitor, SBTI




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Seitz, S. Hess, H. Schulz, R. Eckl, G. Busch, H. P. Montens, R. Brandl, S. Seidl, A. Schomig, and I. Ott
Membrane-Type Serine Protease-1/Matriptase Induces Interleukin-6 and -8 in Endothelial Cells by Activation of Protease-Activated Receptor-2: Potential Implications in Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 769 - 775.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Steinhoff, J. Buddenkotte, V. Shpacovitch, A. Rattenholl, C. Moormann, N. Vergnolle, T. A. Luger, and M. D. Hollenberg
Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response
Endocr. Rev., February 1, 2005; 26(1): 1 - 43.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2004 American Thoracic Society.